Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DB25FY8DV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,031
Award facts
- Contract value 100% obligated
- $13,031.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Kisqali 400 mg daily dose tablets in a quantity of 42 units, with a ceiling value of $13,031.42. This firm fixed price delivery order, which is not set-aside, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider with demonstrated capability to meet federal procurement requirements through competitive processes. The company supplies an extensive portfolio of medical products including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Kisqali, a brand-name cancer treatment medication, exemplifies the specialized pharmaceutical products that AmerisourceBergen delivers through its federal contract vehicles to support military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FY8DV?
SPE2DB25FY8DV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FY8DV worth?
The government has obligated $13,031 on SPE2DB25FY8DV.
Is contract SPE2DB25FY8DV an order under another contract?
Yes. SPE2DB25FY8DV is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8DV competed?
The extent of competition for SPE2DB25FY8DV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award